RISK FACTORS FOR INCIDENCE OF HEMORRHAGIC COMPLICATIONS IN PATIENTS WITH PHILADELPHIA-NEGATIVE MYELOPROLIFERATIVE NEOPLASMS

被引：0
|
作者：
Simonovic, E. [1 ]
Macukanovic-Golubovic, L. [2 ]
机构：
[1] Gen Hosp Leskovac, Internal Med, Leskovac, Serbia
[2] Clin Hematol, Internal Med, Nish, Serbia
来源：
HAEMATOLOGICA | 2017年 / 102卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
PB2061
引用
收藏
页码：819 / 820
页数：2
相关论文
共 50 条
  • [31] Evaluation of thrombin generation in classical Philadelphia-negative myeloproliferative neoplasms
    Olteanu, Ariela Ligia
    Mihaila, Romeo-Gabriel
    Mihalache, Manuela
    REVISTA ROMANA DE MEDICINA DE LABORATOR, 2016, 24 (03): : 279 - 289
  • [32] How we manage Philadelphia-negative myeloproliferative neoplasms in pregnancy
    Robinson, Susan E.
    Harrison, Claire N.
    BRITISH JOURNAL OF HAEMATOLOGY, 2020, 189 (04) : 625 - 634
  • [33] Characteristics and outcomes of young adults with Philadelphia-negative myeloproliferative neoplasms
    Barzilai, Merav
    Kirgner, Ilya
    Avivi, Irit
    Ellis, Martin
    Dally, Najib
    Rozovski, Uri
    Lavi, Noa
    EUROPEAN JOURNAL OF HAEMATOLOGY, 2019, 102 (06) : 504 - 508
  • [34] Towards a Personalized Definition of Prognosis in Philadelphia-Negative Myeloproliferative Neoplasms
    Barbara Mora
    Francesco Passamonti
    Current Hematologic Malignancy Reports, 2022, 17 : 127 - 139
  • [35] Proliferative characteristics of Philadelphia-negative myeloproliferative neoplasms - clinical implications
    Sefer, D.
    Bizic-Radulovic, S.
    Kraguljac-Kurtovic, N.
    Bogdanovic, A.
    Cokic, V.
    Miljic, P.
    Beleslin-Cokic, B.
    Knezevic, V.
    Mitrovic-Ajtic, O.
    Lekovic, D.
    Gotic, M.
    INTERNATIONAL JOURNAL OF LABORATORY HEMATOLOGY, 2017, 39 (01) : 21 - 31
  • [36] Evolving Therapeutic Strategies for the Classic Philadelphia-Negative Myeloproliferative Neoplasms
    Kaplan, Jason B.
    Stein, Brady L.
    McMahon, Brandon
    Giles, Francis J.
    Platanias, Leonidas C.
    EBIOMEDICINE, 2016, 3 : 17 - 25
  • [37] Philadelphia-negative myeloproliferative neoplasms as disorders marked by cytokine modulation
    Cacemiro, Maira da Costa
    Cominal, Jucara Gastaldi
    Tognon, Raquel
    Nunes, Natalia de Souza
    Simoes, Belinda Pinto
    de Figueiredo-Pontes, Lorena Lobo
    Bazzo Catto, Luiz Fernando
    Traina, Fabiola
    Souto, Elizabeth Xisto
    Zambuzi, Fabiana Albani
    Frantz, Fabiani Gai
    de Castro, Fabiola Attie
    HEMATOLOGY TRANSFUSION AND CELL THERAPY, 2018, 40 (02) : 120 - 131
  • [38] Interferon Alfa in the Treatment of Philadelphia-Negative Chronic Myeloproliferative Neoplasms
    Hasselbalch, Hans Carl
    Kiladjian, Jean-Jacques
    Silver, Richard T.
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (18) : E564 - E565
  • [39] Aspirin in Philadelphia-Negative Myeloproliferative Neoplasms: What Is the Optimal Dose ?
    Ajzenberg, Nadine
    Faille, Dorothee
    Huisse, Marie-Genevieve
    Anh Hong Cung
    Lamrani, Lamia
    Dumontier, Nicolas
    Jandrot-Perrus, Martine
    Cassinat, Bruno
    Chomienne, Christine
    Dosquet, Christine
    BLOOD, 2014, 124 (21)
  • [40] Circulating YKL-40 in Philadelphia-negative myeloproliferative neoplasms
    Krecak, Ivan
    Gveric-Krecak, Velka
    Lapic, Ivana
    Roncevic, Pavle
    Gulin, Josipa
    Fumic, Ksenija
    Krecak, Filip
    Holik, Hrvoje
    Durakovic, Nadira
    ACTA CLINICA BELGICA, 2021, 76 (01) : 32 - 39
12345